Pershing Square Sohn Cancer Prize
The PSSCRA Prize funds early-career U.S. scientists for innovative, high-risk cancer research and promotes academia-industry collaboration to accelerate cancer breakthroughs.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to 10% indirect costs); minimum of six awards annually
Summary: Supports early-career U.S.-based scientists to pursue innovative, high-risk cancer research and foster academia–industry collaboration.
Key Information: As of 2026, open to all U.S. institutions and only one LOI per PI per cycle; no full proposal stage.
Description
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) Prize is a prestigious annual award supporting early-career scientists in the United States who are advancing innovative and high-risk cancer research. The program aims to accelerate cancer cures by providing significant funding and access to a unique network of peers, industry mentors, and investors. Recipients are encouraged to pursue bold research ideas that may be too speculative for traditional funding sources, with the goal of catalyzing new discoveries and fostering collaborations between academia and industry.
